Fortrea Holdings Inc (FTRE) Stock Price, Quote & News

Latest News on FTRE

Feb 21, 2025, 3:33 PM EST - 1 day ago

Fortrea to Add Erin L. Russell to Board of Directors

Feb 20, 2025, 7:00 AM EST - 2 days ago

Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research

Jan 30, 2025, 7:00 AM EST - 23 days ago

Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call

Dec 26, 2024, 4:30 AM EST - 2 months ago

Fortrea: Turning Around As The Activists Move In

Nov 26, 2024, 4:15 PM EST - 3 months ago

Fortrea to Present at the Evercore HealthCONx Conference

Nov 26, 2024, 4:15 PM EST - 3 months ago

Fortrea to Present at the Citi Global Healthcare Conference

Nov 8, 2024, 11:21 AM EST - 3 months ago

Fortrea Holdings, Inc. (FTRE) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 6:30 AM EST - 3 months ago

Fortrea Reports Third Quarter 2024 Results

Oct 17, 2024, 7:00 AM EDT - 4 months ago

Fortrea Releases Inaugural Corporate Social Responsibility Report

Oct 14, 2024, 7:00 AM EDT - 4 months ago

Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

Oct 11, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Shareholders to Inquire about Securities Investigation

Oct 10, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings Inc. (FTRE) And Encourages Shareholders to Connect

Oct 9, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Stockholders to Inquire about Securities Investigation

Oct 8, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings Inc. (FTRE) and Encourages Investors to Learn More About the Investigation

Oct 7, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings Inc. (FTRE) And Encourages Investors to Reach Out

Oct 6, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings Inc. (FTRE) And Encourages Stockholders to Reach Out

Oct 2, 2024, 10:00 AM EDT - 5 months ago

Fortrea Holdings Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Sep 30, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings Inc. (FTRE) And Encourages Investors to Connect

Sep 27, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Investors to Inquire about Securities Investigation

Aug 12, 2024, 5:22 PM EDT - 6 months ago

Fortrea Holdings: Continued Troubles

Aug 12, 2024, 1:13 PM EDT - 6 months ago

Fortrea Holdings Inc. (FTRE) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 7:00 AM EDT - 6 months ago

Fortrea Reports Second Quarter 2024 Results

Jul 17, 2024, 7:00 AM EDT - 7 months ago

Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call

Jul 11, 2024, 8:00 AM EDT - 8 months ago

Fortrea Appoints Robert Parks as Chief Accounting Officer

Jun 27, 2024, 7:00 AM EDT - 8 months ago

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

Jun 19, 2024, 5:02 PM EDT - 8 months ago

Fortrea to Participate in Virtual Fireside Chat with Evercore ISI

Jun 4, 2024, 7:00 AM EDT - 9 months ago

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Jun 3, 2024, 7:00 AM EDT - 9 months ago

Market Cap	1.33B
Revenue (ttm)	3.11B
Net Income (ttm)	-3.40M
EPS (ttm)	N/A
PE Ratio	44.60
Forward PE	12.24
Profit Margin	-0.11%
Debt to Equity Ratio	0.74

Volume	830,500
Avg Vol	1,053,670
Day's Range	N/A - N/A
Shares Out	89.70M
Stochastic %K	39%
Beta	1.20
Analysts	Hold
Price Target	$21.80